Skip to content

Clinical trials

Active, not recruiting Phase 1/2 trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 1/2 Status: Active, not recruiting Country / region: China Clear all

168 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20152
20162
20172
20182
20195
20208
202121
202220
202343
202427
202533
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting168

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sichuan Baili Pharmaceutical Co., Ltd.8
Akeso7
AstraZeneca6
Hoffmann-La Roche5
Novartis Pharmaceuticals4
Sun Yat-sen University4
West China Hospital4
Bio-Thera Solutions3
Guangzhou Medical University3
Peking Union Medical College Hospital3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung18
Stomach Neoplasms11
Colorectal Neoplasms9
Breast Neoplasms7
Neoplasms6
Ovarian Neoplasms6
Biliary Tract Neoplasms5
Recurrence5
Squamous Cell Carcinoma of Head and Neck5
Endometrial Neoplasms4

Trials

Showing 1 to 25 of 168. Each trial links to its page on Pharma Observatory.

68 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.